This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Addgene
product type :
cDNA
product name :
pEMS1424
catalog :
29220
citations: 3
Reference |
---|
de Leeuw C, Dyka F, Boye S, Laprise S, Zhou M, Chou A, et al. Targeted CNS Delivery Using Human MiniPromoters and Demonstrated Compatibility with Adeno-Associated Viral Vectors. Mol Ther Methods Clin Dev. 2014;1:5 pubmed
|
product information
Catalog Number :
29220
Product Name :
pEMS1424
article :
doi | 10.1038/s41434-021-00227-z |
id | 28211774 |
pubmed_id | 33531684 |
bacterial resistance :
Ampicillin
cloning :
backbone | pEMS1306 | |||
backbone_mutation | ||||
backbone_origin | ||||
backbone_size | 16454 | |||
promoter | ||||
sequencing_primer_3 | ||||
sequencing_primer_5 | ||||
vector_types |
|
growth notes :
Additional References: 1 Korecki, A. J. et al. Twenty-Seven Tamoxifen-Inducible iCre-Driver Mouse Strains for Eye and Brain, Including Seventeen Carrying a New Inducible-First Constitutive-Ready Allele. Genetics 211, 1155-1177 (2019). 2 de Leeuw, C. N. et al. rAAV-Compatible MiniPromoters for Restricted Expression in the Brain and Eye. Molecular Brain 9, 52 (2016). 3 Scalabrino, M. L. et al. Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. Hum Mol Genet 24, 6229-6239, doi:10.1093/hmg/ddv341, ddv341 [pii] (2015). 4 de Leeuw, C. N. et al. Targeted CNS delivery using human MiniPromoters and demonstrated compatibility with adeno-associated viral vectors. Mol Ther Methods Clin Dev 1, 1-15 (2014).
growth strain :
The plasmid contains the Pleaides (Ple) MiniPromoter Ple155 derived from the human PCP2 gene and designed for expression in ON Bipolar cells of the retina.
growth temp :
DH10B
origin :
37
pi :
|
resistance markers :
928 |
tags :
High Copy
company information
Addgene
490 Arsenal Way, Suite 100
Watertown, MA 02472
Watertown, MA 02472
info@addgene.org
https://www.addgene.org617.225.9000
headquarters: USA
questions and comments